Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
11 min read
Sam North
Yes, cannabis-based therapy options are showing huge promise in helping reduce chronic pain, sleep disturbances, gastrointestinal upset, muscle spasms and stiffness, anxiety, and also the reliance on heavy (and sometimes totally ineffective) pharmaceutical options that come along with the diagnosis of Ehlers-Danlos syndrome (EDS).
Unfortunately, here in the UK, the NHS is unwilling to offer medical cannabis prescriptions to people with Ehlers-Danlos syndrome, due to the lack of clinical evidence on its effectiveness for EDS specifically. However, many individuals with EDS are turning to medical cannabis as a form of alternative/complementary medicine, and the results have been overwhelmingly positive.
Thankfully, private medical cannabis clinics (like Releaf) offer UK patients another way to access medical cannabis when the National Health Service is hesitant to do so.
With Ehlers-Danlos Syndromes Awareness Month finishing up today, we thought it was perfect timing to dive into how medical cannabis may help Ehlers-Danlos Syndrome patients.
Ehlers-Danlos syndrome is a group of thirteen connective tissue disorders, with three types that are most commonly diagnosed.
But, other types of EDS are far rarer. The Ehlers-Danlos Society predict less than 1 in 1 million people are affected by:
EDS is a genetic disorder that is almost always inherited. Unlike some genetic disorders, where both parents need to be carriers of the mutated gene, EDS can be passed down from just one parent. In a very small number of cases, EDS can be caused by a new mutation that appears spontaneously and not through inheritance.
There are more than 19 genes that can cause EDS, and these genes play a role in making collagen. Collagen is a vital protein that provides strength and elasticity to connective tissues. When one or more of these genes mutate, one of the many forms of EDS can be the outcome.
One of the big issues that people with EDS face is misdiagnosis.
The syndrome is often overlooked, in part because the complexity of its symptoms varies from person to person. Genetic testing can confirm the diagnosis by identifying the specific gene mutations, but patients might not be sent for genetic testing if the doctor is not familiar with EDS or its many forms.
The problem is that the presenting symptoms can often masquerade as a variety of other health issues — including fibromyalgia, multiple sclerosis (MS), and lupus. Joint hypermobility and chronic pain are a feature of many other medical conditions, which can lead to an incorrect diagnosis and a delay in treatment.
EDS is a rare condition, and doctors may not have the training or knowledge needed to identify and diagnose it properly. GPs may see the symptoms, try their best to find a cause, and even send the patient off to a specialist—but the specialist might not be familiar with EDS or may be the wrong specialist to diagnose it.
If you think you may have EDS but are struggling to get a diagnosis, it's always worth seeking out the opinion of an EDS specialist. Rheumatologists and geneticists are usually the best doctors to consult with for a EDS diagnosis.
Conventional approaches for EDS focus on managing symptoms and improving quality of life, as there is, unfortunately, no known cure.
Traditional treatments may include:
Yes, at least that's what many people with EDS are finding.
While clinical trials specifically focusing on exactly how medical cannabis options help with reducing the symptoms of EDS are still lacking, there is a wealth of emerging anecdotal evidence and one very interesting case study to look at.
Lucy Stafford, now in her 20s, was diagnosed with EDS and had already had her first surgeries trying to fix her frequent joint dislocations by the age of 10. This was followed by almost permanent hospital stays and another 19 operations during her teenage years.
By the age of 17, she was finding it almost impossible to leave her bed and had been prescribed fentanyl (a synthetic opiate that is around 100 times stronger than heroin), morphine, and buprenorphine to help with her chronic pain, and diazepam (Valium) to help with her anxiety levels.
Despite this cocktail of heavy pharmaceuticals, she was still in pain and had very little quality of life. She is quoted in this BBC article as saying:
"I felt I couldn't focus, I dropped out of school when I was 15. I used to sleep 18 hours a day because I was just so exhausted, and so my muscles wasted. I was at the point where I would have done anything to manage my pain"
Obviously at her wit's end, Lucy decided that enough was enough. After a discussion with her doctor, the decision was made to try medical cannabis. But when her doctor tried to prescribe her medical cannabis, the NHS flatly denied the request.
With no other choice, Lucy boarded a flight to Amsterdam, headed to one of the many 'coffee shops', and tried cannabis. Within a few days of taking her first vaporised cannabis flower, both her chronic pain levels and muscle spasms subsided considerably.
On her return to the UK, she began taking cannabis (first through the black market, but she was quickly able to receive a prescription through a private medical cannabis clinic), and within three months, she had got to the point where she could stop taking all of the opiate medications, and her recurrent bladder infections had ceased.
In this 3 month period, she did not have to go to A&E for emergency treatment at all, but in the three months leading up to this point, she was there five times. In the year before starting medical cannabis treatment, she spent 54 days as a hospital inpatient - in the year after, this dropped to just five days total.
When she was interviewed by the BBC, she said:
"It is literally the only thing that gets me out of bed and being able to work, and being able to study and being able to live a life now." and "I have no idea whether I would still be here if I was on my previous treatment. We were at the end of the line, and it was my last hope, so I would say it saved my life."
These changes to her mobility, pain levels, and overall quality of life are nothing short of extraordinary and have allowed her to start once more with physiotherapy to help further her recovery, where she was previously too tired and sore, and her mobility was too limited to undertake such treatments.
While the evidence here is still largely anecdotal, there are some potentially very good reasons why medical cannabis may be beneficial for those suffering from EDS-related symptoms.
This write-up on the Ehlers-Danlos Support UK website provides some great insight. They interviewed Dr Dani Gordon, a Canadian British doctor now practising in the UK and a leading voice in the medical cannabis field.
“In general, I find medical cannabis is one of the best quality-of-life medications for EDS because it affects multiple systems and symptoms across multiple domains,” says Dr Gordon “EDS is not just about being hypermobile, like many of us are taught in medical school, patients also suffer from a number of symptoms that can be difficult to treat and are often misdiagnosed. When you have this correlation of chronic pain, fatigue and poor sleep, which is often what EDS patients experience, medical cannabis can help with all these symptoms. Although it’s not a cure, in my experience, it often works better, with less side effects than the medications they are currently taking.”
Releaf's medical director, Dr David Tang, added to this with:
"Medical cannabis is showing great promise in treating most, if not all, of the symptoms of EDS. Sleep can be improved; the intensity and frequency of migraines reduced; the impact of chronic pain on day-to-day activities reduced or even eliminated; gastrointestinal symptoms made calmer, and gynaecological pain reduced or eliminated."
"The only caveat is if EDS patients have significant POTS symptoms. Patients new to medical cannabis treatment may find that these symptoms can get worse on occasion, but with time and dosage monitoring, this slight spike in gastrointestinal discomfort is expected to ease for the majority of patients."
Cannabis interacts with our endocannabinoid system, along with a range of other receptor sites in our body, such as those for pain regulation, serotonin, and dopamine.
The endocannabinoid system is a homeostatic system that works to bring balance to the brain and the body in many different ways. It is the largest neurotransmitter system in the body, and its receptors are found throughout the central and peripheral nervous systems.
The endocannabinoid system helps to regulate pain perception, inflammation, immune responses, mood, sleep, appetite, digestion, and many other bodily functions. It is also involved in neuroprotection and neuroregeneration processes.
In the Ehlers-Danlos Support UK website article, Dr Dani Gordon puts it this way
"Just like many other chronic conditions with symptoms that cross multiple systems in the body, EDS is one of those diseases where medical cannabis is particularly beneficial, because there are cannabinoid receptors in most of our tissues throughout the brain and body, and the endocannabinoid system has so many diverse functions. Because of this, we tend to see relief from symptoms that don't necessarily appear to be connected."
And then there are the secondary symptoms of EDS, like anxiety, depression, and PTSD. For many people with these conditions, medical cannabis can be a real game-changer.
While clinical research is still lacking, hopefully, in the coming years, more scientific investigation will be carried out to work out the precise mechanisms behind how medical cannabis helps those with EDS. But for now, the anecdotal evidence combined with the emerging science seems to be pointing in a very promising direction.
If you would like to learn more about the potential benefits of medical cannabis for EDS, feel free to reach out at any time. We also have an extensive blog and education section, where you can find more information on all things medical cannabis.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
Our articles are written by experts and reviewed by medical professionals or compliance specialists. Adhering to stringent sourcing guidelines, we reference peer-reviewed studies and scholarly research. View our editorial policy.
Need more help?
In today's write-up, we will explain all the factors that can and do affect the price of medical cannabis cultivars. Here at Releaf, we want to ensure that our patients are well-informed about their medication options, including the pricing factors.
Sam North
In the last two decades, global plastic production has doubled, with 400 million tonnes of plastic waste now produced every year. As one of the only UK clinics to provide medical cannabis flower in eco-friendly packaging, Releaf is committed to finding more sustainable solutions this Plastic Free July and is taking steps towards a plastic-free future.
Sarah Sinclair
Medical cannabis was legalised in the UK in 2018 for patients with health conditions known to respond to cannabis-based treatments, if conventional or licensed medications have failed to meet their needs. Because one of these health conditions is Multiple Sclerosis, Releaf are joining MS-UK for a free Webinar on the 21st of August, to explain how these treatments can be safely incorporated into MS treatment plans.
Lucy MacKinnon
